|
1
|
Zhou ZG, Gao XS, Qiao XY and Zhang P:
Literature analysis of radiotherapy for esophageal cancer in China.
Chin J Cancer. 29:873–881. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schneider BJ and Urba SG: Preoperative
chemoradiation for the treatment of locoregional esophageal cancer:
The standard of care? Semin Radiat Oncol. 17:45–52. 2007.
View Article : Google Scholar
|
|
3
|
Shibata T, Kokubu A, Saito S,
Narisawa-Saito M, Sasaki H, Aoyagi K, Yoshimatsu Y, Tachimori Y,
Kushima R, Kiyono T, et al: NRF2 mutation confers malignant
potential and resistance to chemoradiation therapy in advanced
esophageal squamous cancer. Neoplasia. 13:864–873. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fokas E, Weiss C and Rödel C: The role of
radiotherapy in the multimodal management of esophageal cancer. Dig
Dis. 31:30–37. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luthra R, Wu TT, Luthra MG, Izzo J,
Lopez-Alvarez E, Zhang L, Bailey J, Lee JH, Bresalier R, Rashid A,
et al: Gene expression profiling of localized esophageal
carcinomas: Association with pathologic response to preoperative
chemoradiation. J Clin Oncol. 24:259–267. 2006. View Article : Google Scholar
|
|
6
|
Wu X, Gu J, Wu TT, Swisher SG, Liao Z,
Correa AM, Liu J, Etzel CJ, Amos CI, Huang M, et al: Genetic
variations in radiation and chemotherapy drug action pathways
predict clinical outcomes in esophageal cancer. J Clin Oncol.
24:3789–3798. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang JX, Tong ZT, Yang L, Wang F, Chai
HP, Zhang F, Xie MR, Zhang AL, Wu LM, Hong H, et al: PITX2: A
promising predictive biomarker of patients' prognosis and
chemoradioresistance in esophageal squamous cell carcinoma. Int J
Cancer. 132:2567–2577. 2013. View Article : Google Scholar
|
|
8
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:15524–15529. 2002. View Article : Google Scholar
|
|
9
|
Liu Z, Jin ZY, Liu CH, Xie F, Lin XS and
Huang Q: MicroRNA-21 regulates biological behavior by inducing EMT
in human cholangiocarcinoma. Int J Clin Exp Pathol. 8:4684–4694.
2015.PubMed/NCBI
|
|
10
|
Yang X, Ye J, Yan H, Tang Z, Shen 1, Zhang
J and Yang L: MiR-491 attenuates cancer stem cells-like properties
of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated
EMT. Tumour Biol. Jul 19–2015.Epub ahead of print.
|
|
11
|
Chang YL, Zhou PJ, Wei L, Li W, Ji Z, Fang
YX and Gao WQ: MicroRNA-7 inhibits the stemness of prostate cancer
stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21
pathway. Oncotarget. 6:24017–24031. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cui R, Meng W, Sun HL, Kim T, Ye Z, Fassan
M, Jeon YJ, Li B, Vicentini C, Peng Y, et al: MicroRNA-224 promotes
tumor progression in nonsmall cell lung cancer. Proc Natl Acad Sci
USA. 112:E4288–E4297. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li W, Shen S, Wu S, Chen Z, Hu C and Yan
R: Regulation of tumorigenesis and metastasis of hepatocellular
carcinoma tumor endothelial cells by microRNA-3178 and underlying
mechanism. Biochem Biophys Res Commun. 464:881–887. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao L, Bode AM, Cao Y and Dong Z:
Regulatory mechanisms and clinical perspectives of miRNA in tumor
radiosensitivity. Carcinogenesis. 33:2220–2227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schwarzenbach H, Nishida N, Calin GA and
Pantel K: Clinical relevance of circulating cell-free microRNAs in
cancer. Nat Rev Clin Oncol. 11:145–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Erson AE and Petty EM: MicroRNAs in
development and disease. Clin Genet. 74:296–306. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar :
|
|
21
|
Kroh EM, Parkin RK, Mitchell PS and Tewari
M: Analysis of circulating microRNA biomarkers in plasma and serum
using quantitative reverse transcription-PCR (qRT-PCR). Methods.
50:298–301. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Webster RJ, Giles KM, Price KJ, Zhang PM,
Mattick JS and Leedman PJ: Regulation of epidermal growth factor
receptor signaling in human cancer cells by microRNA-7. J Biol
Chem. 284:5731–5741. 2009. View Article : Google Scholar
|
|
23
|
Buckley AF, Burgart LJ, Sahai V and Kakar
S: Epidermal growth factor receptor expression and gene copy number
in conventional hepatocellular carcinoma. Am J Clin Pathol.
129:245–251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kefas B, Godlewski J, Comeau L, Li Y,
Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S, et
al: microRNA-7 inhibits the epidermal growth factor receptor and
the Akt pathway and is down-regulated in glioblastoma. Cancer Res.
68:3566–3572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reddy SD, Ohshiro K, Rayala SK and Kumar
R: MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase
1 and regulates its functions. Cancer Res. 68:8195–8200. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fang Y, Xue JL, Shen Q, Chen J and Tian L:
MicroRNA-7 inhibits tumor growth and metastasis by targeting the
phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Hepatology. 55:1852–1862. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok
MT, Wang H, Chen J, Ng SS, Chen M, et al: microRNA-7 is a novel
inhibitor of YY1 contributing to colorectal tumorigenesis.
Oncogene. 32:5078–5088. 2013. View Article : Google Scholar
|
|
28
|
Li X and Carthew RW: A microRNA mediates
EGF receptor signaling and promotes photoreceptor differentiation
in the Drosophila eye. Cell. 123:1267–1277. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pogribny IP, Filkowski JN, Tryndyak VP,
Golubov A, Shpyleva SI and Kovalchuk O: Alterations of microRNAs
and their targets are associated with acquired resistance of MCF-7
breast cancer cells to cisplatin. Int J Cancer. 127:1785–1794.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee KM, Choi EJ and Kim IA: microRNA-7
increases radiosensitivity of human cancer cells with activated
EGFR-associated signaling. Radiother Oncol. 101:171–176. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dong W, Li B, Wang Z, Zhang Z and Wang J:
Clinical significance of microRNA-24 expression in esophageal
squamous cell carcinoma. Neoplasma. 62:250–258. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Miller AB, Hoogstraten B, Staquet M and
Winkler A: Reporting results of cancer treatment. Cancer.
47:207–214. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schmittgen TD, Lee EJ and Jiang J:
High-throughput real-time PCR. Methods Mol Biol. 429:89–98. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wieder HA, Brücher BL, Zimmermann F,
Becker K, Lordick F, Beer A, Schwaiger M, Fink U, Siewert JR, Stein
HJ, et al: Time course of tumor metabolic activity during
chemoradiotherapy of esophageal squamous cell carcinoma and
response to treatment. J Clin Oncol. 22:900–908. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Suzuki A, Xiao L, Hayashi Y, Macapinlac
HA, Welsh J, Lin SH, Lee JH, Bhutani MS, Maru DM, Hofstetter WL, et
al: Prognostic significance of baseline positron emission
tomography and importance of clinical complete response in patients
with esophageal or gastroesophageal junction cancer treated with
definitive chemoradiotherapy. Cancer. 117:4823–4833. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vaupel P and Harrison L: Tumor hypoxia:
Causative factors, compensatory mechanisms, and cellular response.
Oncologist. 9(Suppl 5): S4–S9. 2004. View Article : Google Scholar
|
|
37
|
Jamal M, Rath BH, Williams ES, Camphausen
K and Tofilon PJ: Microenvironmental regulation of glioblastoma
radioresponse. Clin Cancer Res. 16:6049–6059. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Thoms J and Bristow RG: DNA repair
targeting and radiotherapy: A focus on the therapeutic ratio. Semin
Radiat Oncol. 20:217–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Langerak P and Russell P: Regulatory
networks integrating cell cycle control with DNA damage checkpoints
and double-strand break repair. Philos Trans R Soc Lond B Biol Sci.
366:3562–3571. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chou CH, Chen SU and Cheng JC:
Radiation-induced interleukin-6 expression through
MAPK/p38/NF-kappaB signaling pathway and the resultant
antiapoptotic effect on endothelial cells through Mcl-1 expression
with sIL6-Ralpha. Int J Radiat Oncol Biol Phys. 75:1553–1561. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jiang L, Liu X, Chen Z, Jin Y, Heidbreder
CE, Kolokythas A, Wang A, Dai Y and Zhou X: MicroRNA-7 targets
IGF1R (insulin-like growth factor 1 receptor) in tongue squamous
cell carcinoma cells. Biochem J. 432:199–205. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kong X, Li G, Yuan Y, He Y, Wu X, Zhang W,
Wu Z, Chen T, Wu W, Lobie PE, et al: MicroRNA-7 inhibits
epithelial-to-mesenchymal transition and metastasis of breast
cancer cells via targeting FAK expression. PLoS One. 7:e415232012.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu X, Jiang L, Wang A, Yu J, Shi F and
Zhou X: MicroRNA-138 suppresses invasion and promotes apoptosis in
head and neck squamous cell carcinoma cell lines. Cancer Lett.
286:217–222. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu X, Yu J, Jiang L, Wang A, Shi F, Ye H
and Zhou X: MicroRNA-222 regulates cell invasion by targeting
matrix metalloproteinase 1 (MMP1) and manganese superoxide
dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines.
Cancer Genomics Proteomics. 6:131–139. 2009.PubMed/NCBI
|
|
45
|
Kunisaki C, Imada T, Yamada R, Hatori S,
Kinbara K, Watai K, Akiyama H, Nomura M, Matsuda G, Otsuka Y, et
al: Prognostic factors after chemoradiotherapy for patients with
inoperable esophageal squamous cell carcinoma.
Hepatogastroenterology. 53:366–371. 2006.PubMed/NCBI
|
|
46
|
Wakatsuki M, Suzuki Y, Nakamoto S, Ohno T,
Ishikawa H, Kiyohara H, Kiyozuka M, Shirai K, Nakayama Y and Nakano
T: Clinical usefulness of CYFRA 21-1 for esophageal squamous cell
carcinoma in radiation therapy. J Gastroenterol Hepatol.
22:715–719. 2007.PubMed/NCBI
|
|
47
|
Yi Y, Li B, Wang Z, Sun H, Gong H and
Zhang Z: CYFRA21-1 and CEA are useful markers for predicting the
sensitivity to chemoradiotherapy of esophageal squamous cell
carcinoma. Biomarkers. 14:480–485. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liccardi G, Hartley JA and Hochhauser D:
EGFR nuclear translocation modulates DNA repair following cisplatin
and ionizing radiation treatment. Cancer Res. 71:1103–1114. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Szumiel I: Epidermal growth factor
receptor and DNA double strand break repair: The cell's
self-defence. Cell Signal. 18:1537–1548. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kriegs M, Kasten-Pisula U, Rieckmann T,
Holst K, Saker J, Dahm-Daphi J and Dikomey E: The epidermal growth
factor receptor modulates DNA double-strand break repair by
regulating non-homologous end-joining. DNA Repair. 9:889–897. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kalinowski FC, Giles KM, Candy PA, Ali A,
Ganda C, Epis MR, Webster RJ and Leedman PJ: Regulation of
epidermal growth factor receptor signaling and erlotinib
sensitivity in head and neck cancer cells by miR-7. PLoS One.
7:e470672012. View Article : Google Scholar : PubMed/NCBI
|
